Inhibition of virulence potential of Vibrio cholerae by natural compounds.
The rise in multi-drug resistant Vibrio cholerae strains is a big
problem in treatment of patients suffering from severe cholera. Only a
few studies have evaluated the potential of natural compounds against V
cholerae. Extracts from plants like 'neem',
'guazuma', 'daio', apple, hop, green tea and
elephant garlic have been shown to inhibit bacterial growth or the
secreted cholera toxin (CT). However, inhibiting bacterial growth like
common antimicrobial agents may also impose selective pressure
facilitating development of resistant strains. A natural compound that
can inhibit virulence in V cholerae is an alternative choice for remedy.
Recently, some common spices were examined to check their inhibitory
capacity against virulence expression of V. cholerae. Among them
methanol extracts of red chili, sweet fennel and white pepper could
substantially inhibit CT production. Fractionation of red chili methanol
extracts indicated a hydrophobic nature of the inhibitory compound(s),
and the n-hexane and 90 per cent methanol fractions could inhibit >90
per cent of CT production. Purification and further fractionation
revealed that capsaicin is one of the major components among these red
chili fractions. Indeed, capsaicin inhibited the production of CT in
various V. cholerae strains regardless of serogroups and biotypes. The
quantitative reverse transcription real-time PCR assay revealed that
capsaicin dramatically reduced the expression of major virulence-related
genes such as ctxA, tcpA and toxT but enhanced the expression of hns
gene that transcribes a global prokaryotic gene regulator (H-NS). This
indicates that the repression of CT production by capsaicin or red chili
might be due to the repression of virulence genes transcription by H-NS.
Regular intake of spices like red chili might be a good approach to
fight against devastating cholera.
Key words Capsaicin--cholera toxin--real-time PCR--spice--Vibrio cholerae
Cholera (Causes of)
Cholera (Care and treatment)
Plant products (Health aspects)
Neogi, Sucharit Basu
|Publication:||Name: Indian Journal of Medical Research Publisher: Indian Council of Medical Research Audience: Academic Format: Magazine/Journal Subject: Biological sciences; Health Copyright: COPYRIGHT 2011 Indian Council of Medical Research ISSN: 0971-5916|
|Issue:||Date: Feb, 2011 Source Volume: 133 Source Issue: 2|
|Geographic:||Geographic Scope: India Geographic Code: 9INDI India|
Cholera is an acute diarrhoeal disease which is characterized by discharge of voluminous rice water stool caused by toxigenic Vibrio cholerae strains. V. cholerae O1 and O139 serogroups producing cholera toxin (CT) are mainly responsible for cholera outbreaks that can cause havoc in highly populated regions in Asia, Africa, and Latin America (1). V. cholerae O1 is further divided into El Tor and classical biotypes. The ongoing pandemic of cholera that started in 1961 is caused by O1 El Tor biotype, which replaced O1 classical strains that caused previous six pandemics. The O139 serogroup evolved as a new epidemic strain in 1992 (2). Currently, the El Tor variant strains possessing classical type ctx genes are mainly responsible for cholera outbreaks in many developing countries (3). Strains of V. cholerae, which do not belong to O1 or O139 serogroups are commonly called as non-O1/non-O139, some of them are toxigenic and can cause sporadic cases of diarrhoea (4). In serious cases, the infection can produce an acute state of dehydration within several hours and if untreated, can be fatal. Among various virulence factors reported in V. cholerae, CT (encoded on a filamentous phage called CTX-[PHI]) consisting of one A and five B subunits and the toxin co-regulated pilus (TCP) are the most important factors associated with severity of the illness. TCP can act as a receptor for CTX-[PHI] and also aid in bacterial colonization in our intestine (5).
Oral rehydration solution (ORS) is a commonly used therapy for cholera that aids recovery from dehydration. However, due to the severity of the disease, antimicrobial agents are most often administered in addition to intake of ORS. Unfortunately, through mutation and the selective pressure exerted by the antimicrobial agents, V. cholerae strains have been increasingly becoming resistant to commonly used antimicrobial agents. In the past two decades, most of the V. cholerae strains in cholera endemic countries have become resistant to many antimicrobial agents including tetracycline, ampicillin, nalidixic acid, streptomycin, sulphonamides, trimethoprim, gentamicin, ciprofloxacin etc. (6-8). The emergence and spread of multi-drug resistant (MDR) pathogenic bacteria have created the need for the development of novel therapeutic agents. Conventional antimicrobial agents are generally bacteriocidal or bacteriostatic which may foster the development of MDR strains. Alternatively, inhibiting bacterial virulence factor by natural compounds is a new approach to overcome increased antimicrobial resistance in pathogenic bacteria. Commonly used natural products like spices, herbs, fruits, etc. have many kinds of beneficial effects to our health. In India, Ayurveda, a comprehensive medical system that utilizes natural products, has been used to cure many diseases including diarrhoea since ancient time. Spices and herbs have also been traditionally used to treat diarrhoeal diseases in other parts of the world. Natural products have less side effects and thus advantageous for therapeutic purpose. Recently, we have observed that extracts from some common spices can repress CT production in V. cholerae. Natural compounds, which can directly inhibit virulence gene expression in V. cholerae, may be used along with intake of ORS for treating devastating cholera.
Plant products as remedy for diarrhoea
The beneficial health effects of many plants, used for centuries as seasoning agents in food and beverages, have been claimed for not only preventing food deterioration but also acting as antimicrobials against pathogenic microorganisms. A few studies have been carried out in a systematic manner, although phytochemical and pharmacological investigations of several plants have already led to the isolation of some of the natural antimicrobials (9). Scientists are searching for natural products that can be used in large scale to reduce diarrhoea caused by vibrios. Some natural compounds have been examined to act against bacterial growth whereas little is known about specific influence on their virulence regulation.
The use of natural products as medicine has dramatically increased in the last two decades. Wasabi (Wasabi japonica), a traditional spice used with raw fish (e.g., sushi) in Japan, has been shown to have antimicrobial effect against some bacteria including V. parahaemolyticus (10). Among the natural compounds possessing antimicrobial activity, a few have been tested against V. cholerae. Japanese green tea (Camellia sinensis) has been shown to inhibit both the growth and CT expression of V. cholerae in experimental animal (11). Some plant polyphenols (e.g., procyanidins, gallate analogues, apelphenon, etc.) can also suppress CT activity in rabbit ileal loop or by repressing its binding to the Vero and CHO cells (12-15). However, these polyphenols can act on the purified or extracellular CT but not on virulence expression of V. cholerae. Extracts from 'neem' (Azadirachta indica) and 'elephant garlic' have also been shown to inhibit V. cholerae growth (16,17). However, any kind of antimicrobial agent targeting bacterial viability may impose selective pressure facilitating development of antimicrobial resistance. Red bayberry has the potential to inhibit the CT production in V. cholerae at sub-bacteriocidal concentration (18). We have recently identified that red chili and one of its active compounds called capsaicin can inhibit CT production in V. cholerae without affecting bacterial growth (19). This kind of compounds inhibiting virulence expression may impose less selective pressure on the development of antimicrobial resistance (20). A list of natural compounds so far identified to act against diarrhoeagenic vibrios is shown in Table I.
Inhibition of CT production in V. cholerae by spice extracts
Some spices (e.g., red chili, sweet fennel, pepper, cassia bark, etc.) are known to act as anti-inflammatory, anticancer, antimicrobial or antifungal agents (21,22). However, there is very limited knowledge on the effect of spices on virulence regulation in pathogens. Ginger has been reported to block the heat-labile enterotoxin in Escherichia coli (23). We have recently examined whether some spices contain any compound which can inhibit the virulence expression of various V. cholerae strains, in particular, recently emerged V. cholerae O1 El Tor variant (19). Some culinary spices, which are commonly available in cholera endemic countries in South East Asia and age cost-effective were selected for this purpose.
Initially, four V. cholerae El Tor strains belonging to the recently emerged El Tor variant were tested against methanol extracts of red chili, sweet fennel, white pepper, red pepper, cassia bark and star anise. Spices were ground to fine powder and extracted with 99.9 per cent methanol and added to bacterial culture after appropriate dilutions. The selected strains were cultured at 37[degrees]C in AKI medium, pH 7.4 (24) with and without methanol extract of each spice. Cell free culture supernatant (CFS) was prepared by centrifugation followed by filtration through 0.22 [micro]m filter. CT was purified as described previously (25) and used as a control to quantify the concentration of CT in cultures using a previously established bead enzyme-linked immunosorbent assay (bead-ELISA) (26). Before CFS preparation, each culture was serially diluted with phosphate buffer saline (PBS) and spread on Luria Bertani (LB) agar (Difco, KS, USA). Numbers of colonies were counted after overnight incubation at 37[degrees]C. It was observed that all the spices extracts (each 100 [micro]g/ml) had high inhibitory activity against CT production in most of the cases (Table II). Red chili, sweet fennel and white pepper showed comparatively higher inhibitory effect (>80%) against CT production in V. cholerae strains than other spices (19). The inhibitory effect on CT production in V. cholerae varied from strain to strain, e.g., 45-86 per cent inhibition with cassia bark and 5380 per cent inhibition with red pepper extracts. Star anise extract had lower inhibitory effect (6-66%) on CT production when compared to other spice extracts (our unpublished data). The spice extracts (100 [micro]g/ml) did not show any impact on bacterial growth during 1, 2, 4 and 8 h sampling time (data not shown).
Among the six spices, red chili methanol extract showed potential inhibitory effect against CT production in V. cholerae. Red chili is an easily available natural spice and commonly used in cholera endemic regions like India and other countries in South-East Asia and Africa. The red chili extract was fractionated to purify and identify the active compounds, firstly, with aqueous/ethyl acetate mixture, then the aqueous extract was further fractionated with n-butanol while the ethyl acetate extract was further fractionated with n-hexane and 90 per cent methanol. When all these extracts were applied to the culture of a representative El Tor variant strain (CRC41), most of the inhibitory activity against CT production was detected in n-hexane and 90 per cent methanol extracts although weak inhibitory activity was also observed in other extracts (Fig. 1). The nature of such compounds responsible for CT inhibitory effect could be hydrophobic. Similarly, 90 per cent methanol extracts of sweet fennel and white pepper also showed high inhibitory effect on CT production (our unpublished data). Further fractionation of n-hexane and 90 per cent methanol extracts of red chili by silica gel and thin layer chromatography revealed that the fractions with strong inhibitory activity against CT production contained capsaicin (19), a major component of red chili and mixture of fatty acids (our unpublished data). The inhibitory effects against CT production by both of these components were verified (Fig. 1). It has been reported that some fatty acids or their derivatives from microorganisms or plants are also sources for antimicrobial agent (27,28) against Gram-positive as well as Gram-negative bacteria (29). Recently, the role of unsaturated fatty acid from bile source to inhibit CT production in V. cholerae classical strain has been illustrated (30).
[FIGURE 1 OMITTED]
Efficacy of capsaicin as inhibitory agent against CT production
Capsaicin (N-anillyl-8-methyl-nonenamide) is one of the active ingredients in red chili which can act as an antimicrobial agent against bacterial pathogens such as Bacillus spp., Helicobacter pylori, etc. (31,32). Besides, use of natural compounds like red chili or its derivatives like capsaicin as food supplement is advantageous because it is not harmful to common flora in human intestine (32). Recently, we have extensively studied inhibitory activity of capsaicin on CT production in V. cholerae strains collected in various countries and years from 1948 to 2006 (19). Twenty three V. cholerae strains belonging to various serogroups and CT genotypes were selected. The ctxB genotyping of the selected strains was performed by mismatch amplification mutation (MAMA)-PCR assay (33). It was observed that capsaicin could inhibit CT production in all kind of toxigenic V. cholerae strains, i.e., strains belonging to El Tor variant, El Tor, classical, O139 as well as non-O1/non-O139 (Fig. 2). Furthermore, we also observed that capsaicin inhibited CT production in a dose-dependent manner. Capsaicin could inhibit CT production strongly in all strains without affecting their growth, e.g., in case of El Tor strains (n=5) the inhibition was 70-99 per cent, in case of the recently emerged El Tor variant strains (n=12) producing classical type CT it was 90-99 per cent, in case of classical strains (n=2) it was 78-90 per cent, in case of O139 strains (n=2) it was 85-95 per cent and in case of CT-producing non-O1/non-O139 strains it was 90-95 per cent (Fig. 2).
Recent cholera epidemics predominantly caused by the El Tor variant strains in many developing countries is a matter of concern because of the higher pathogenic potential of these variant strains (3,34). One of the reasons could be higher CT production by El Tor variant strains possessing classical ctxB gene allele than typical El Tor (35). The result of our study also showed similar trend, i.e., higher CT production among El Tor variant strains (19). However, our results indicate that the inhibitory impact of capsaicin is not influenced by the amount of CT production by various V. cholerae strains. Importantly, capsaicin can effectively inhibit CT production not only in El Tor variants but also in typical El Tor, O139, classical as well as in non-O1/ non-O139 strains (Fig. 2) (19).
Inhibition of transcription of virulence and regulatory genes of V. cholerae by red chili and capsaicin
Expression of CT and TCP is activated by the expression of ToxT which in turn is regulated by TcpP/TcpH and ToxR/ToxS (36,37). On the contrary, histone-like nucleoid structuring protein (H-NS) encoded by the hns gene, a global prokaryotic gene regulator, has been shown to repress the transcription of several virulence genes including toxT, ctx and tcpA (38). To analyze the inhibitory mechanisms of red chili or one of its major components capsaicin on CT production in V. cholerae strains, quantitative reverse transcription real time PCR (qRT-PCR) analysis was performed using a representative strain belonging to V. cholerae O1 El Tor variant. This strain was grown with and without red chili extract or capsaicin. Total RNA was extracted and qRT-PCR was performed following TaqMan probe method. Red chili extract repressed the transcription of ctxA gene more than 43-fold (P<0.01) whereas capsaicin repressed it about 23-fold (P<0.01) (Fig. 3) (19). The influence of capsaicin (100 [micro]g/ml) was further checked targeting transcription of tcpA, toxT, toxR, toxS, tcpP, tcpH and hns genes (19). Transcription of some of these genes was also repressed by capsaicin, e.g., tcpA (6.3-fold; P<0.01), toxT (4.0 fold; P<0.01), tcpP (2.7 fold; P<0.05) and tcpH (2.5-fold; P<0.05) (Fig. 3). Interestingly, transcription of hns was enhanced more than two times by capsaicin (P<0.01) (19). In the qRT-PCR assay the transcription of recA, a housekeeping gene used as control, was not affected in the presence or absence of red chili extract and capsaicin.
[FIGURE 2 OMITTED]
[FIGURE 3 OMITTED]
Reduction in the transcription of ctxA, tcpA and toxT genes in the presence of capsaicin may be due to the inhibitory effect of capsaicin on ToxT (Figs 3 and 4). Previous study has also reported that a synthetic compound virstatin (4-[N-(1,8-naphthalimide)]-n-butyric acid) can inhibit CT production in a ToxT dependent manner (39). However, it has been shown earlier that H-NS negatively regulates the transcription of toxT, ctx and tcpA genes (38). Another study has demonstrated that in the presence of bile hns can also repress ctx and tcpA transcriptions in a ToxT independent manner (30). As capsaicin could enhance hns gene transcription (Fig. 3), it is plausible that hns may play a critical role in the reduction of transcriptions of ctxA and tcpA (19). Therefore, capsaicin may directly or indirectly activate the hns transcription which in turn downregulates the transcription of toxT, ctxA and tcpA genes (Figs. 3 and 4). Besides, capsaicin may directly repress the transcription of these three genes (Fig. 4). In case of the transcription of toxR/toxS regulatory genes capsaicin had no impact but the compound repressed tcpP/tcpH transcription (Fig. 3). ToxR is believed to instigate CT production by inducing toxT transcription via synergistic coupling of ToxR/ ToxS and TcpP/TcpH (37). These data suggest that capsaicin could repress transcription of virulence genes via induction of hns in a ToxR-independent manner (Fig. 4). However, red chili extract showed higher inhibitory impact in comparison to capsaicin which indicates the possibility of having other unidentified compound(s) in red chili that can directly inhibit or synergistically act with capsaicin. We have noticed that fatty acid mixture fraction of red chili extract can also inhibit CT production (Fig. 1). Further studies regarding the purification of other active compound(s) present in red chili and other spices extracts as well as in vivo study with sub-bacteriocidal concentration of spices extracts are ongoing in our laboratory.
[FIGURE 4 OMITTED]
Various natural compounds can be used to treat cholera in parallel to the conventional therapeutic agents. Particularly, spices like red chili, white pepper and sweet fennel can inhibit CT production in V. cholerae. As these spices act against virulence expression rather than the viability of V. cholerae there is less chance of developing resistance. One of the active compounds present in red chili is capsaicin, which can inhibit CT production in V. cholerae strains regardless of their serogroups and biotypes. The inhibitory mechanism of CT production by capsaicin is probably due to the H-NS mediated inhibition of the transcription of major virulence genes such as ctx and tcpA genes. Regular intake of commonly available and inexpensive spices (especially, red chili, sweet fennel and white pepper) can be a possible approach to reduce the disease vulnerability from V. cholerae.
Received June 14, 2010
This work was supported in part by a grant from Yamazaki Spice Promotion Foundations, Japan.
(1.) Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet 2004; 363 : 23-33.
(2.) Ramamurthy T, Yamasaki S, Takeda Y, Nair GB. Vibrio cholerae O139 Bengal: Odyssey of a fortuitous variant. Microbes Infect 2003; 5 : 329-44."
(3.) Raychoudhuri A, Mukhopadhyay AK, Ramamurthy T, Nandy RK, Takeda Y, Nair GB. Biotyping of Vibrio cholerae O1: Time to redefine the scheme. Indian J Med Res 2008; 128 : 695-8.
(4.) Chatterjee S, Ghosh K, Roychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay AK, et al. Incidence, virulence factors and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India. J Clin Microbiol 2009; 47: 1087-95.
(5.) Waldar MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 2006; 272: 1910-4.
(6.) Garg P, Chakraborty S, Basu I, Datta S, Rajendran K, Bhattacharya T, et al. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect 2000; 124: 393-9.
(7.) Chakraborty S, Garg P, Ramamurthy T, Thungapathra M, Gautam JK, Kumar C, et al. Comparison of antibiogram, virulence genes, ribotypes and DNA fingerprints of Vibrio cholerae of matching serogroups isolated from hospitalised diarrhoea cases and from the environment during 1997-1998 in Calcutta, India. J Med Microbiol 2001; 50: 879-88.
(8.) Das S, Saha R, Kaur IR. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi. Indian J Med Res 2008; 127: 478-82.
(9.) Iwu MW, Duncan AR, Okunjii CO. New antimicrobials of plant origin. In: Alexandria Janick J, editor. Perspectives on new crops and new uses. Virginia: ASHS Press; 1999. p. 457-62.
(10.) Hasegawa N, Matsumoto Y, Hoshino A, Iwashita K. Comparison of effects of Wasabia japonica and allyl isothiocyanate on the growth of four strains of Vibrio parahaemolyticus in lean and fatty tuna meat suspensions. Int J Food Microbiol 1999; 49: 27-34.
(11.) Toda M, Okubo S, Ikigai H, Suzuki T, Suzuki Y, Hara Y, et al. The protective activity of tea catechins against experimental infection by Vibrio cholerae O1. Microbiol Immunol 1992; 36: 999-1001.
(12.) Hor M, Rimpler H, Heinrich M. Inhibition of intestinal chloride secretion by proanthocyanidins from Guazuma ulmifolia. Planta Medica 1995; 61: 208-12.
(13.) Oi H, Matsuura D, Miyake M, Ueno M, Takai I, Yamamoto T, et al. Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation. Proc Natl Acad Sci USA 2002; 99: 3042-6.
(14.) Saito T, Miyake M, Toba M, Okamatsu H, Shimizu S, Noda M. Inhibition by apple polyphenols of ADP-ribosyltransferase activity of cholera toxin and toxin-induced fluid accumulation in mice. Microbiol Immunol 2002; 46: 249-55.
(15.) Morinaga N, Iwamura Y, Yahiro K, Tagashira M, Moss J, Noda M. Differential activities of plant polyphenols on the binding and internalization of cholera toxin in vero cells. J Biol Chem 2005; 280: 23303-9.
(16.) Thakurta P, Bhowmik P, Mukherjee S, Hajra TK, Patra A, Bag PK. Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India. J Ethnopharmacol 2007; 111: 607-12.
(17.) Rattanachaikunsopon P, Phumkhachorn P. Antimicrobial activity of elephant garlic oil against Vibrio cholerae in vitro and in food model. Biosci Biotechnol Biochem 2009; 73: 1-5.
(18.) Zhong Z, Yu Z, Zhu J. Red bayberry extract inhibits growth and virulence gene expression of the human pathogen Vibrio cholerae. J Antimicrob Chemother 2008; 61: 753-4.
(19.) Chatterjee S, Asakura M, Chowdhury N, Neogi SB, Sugimoto N, Haldar S, et al. Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae. FEMS Microbiol Lett 2010; 306: 54-60.
(20.) Clatworthy AE, Pierson E, Hung DT. Targeting virulence: a new paradigm for antimicrobial therapy. Nat Chem Biol 2007; 3: 541-8.
(21.) Low DT. A reason to season: the therapeutic benefits of spices and culinary herbs. Explore (NY) 2006; 2: 446-9.
(22.) Aggarwal BB, Ajaikumar AB, Harikumar KB, Tharakan ST, Sung B, Anand P. Potential of spice derived phytochemicals for cancer prevention. Planta Med 2008; 74: 1560-9.
(23.) Chen JC, Huang LJ, Wu SL, Kuo SC, Ho TY, Hsaing CY. Ginger and its bioactive component inhibit enterotoxicogenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice. J Agric Food Chem 2007; 55: 8390-7.
(24.) Iwanaga M, Yamamoto K, Higa N, Ichinose Y, Nakasone N, Tanabe M. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor. Microbiol Immunol 1986; 30: 1075-83.
(25.) Uesaka Y, Otsuka Y, Lin Z, Yamasaki S, Yamaoka J, Kurazano H, et al. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb Pathog 1994; 16: 71-6.
(26.) Oku Y, Uesaka Y, Hirayama T, Takeda Y. Development of a highly sensitive bead-ELISA to detect bacterial protein toxins. Microbiol Immunol 1988; 32: 807-16.
(27.) Pfefferle C, Kempter C, Metzger JW, Fiedler HP. E-4-oxonon-2-enoic acid, an antibiotically active fatty acid produced by Streptomyces olivaceus Tu 4018. J Antibiot 1996; 49: 826-8.
(28.) Dellar JE, Cole MD, Waterman PG. Unusual antimicrobial compounds from Aeollanthus buchnerianus. Experientia 1996; 52: 175-9.
(29.) Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acid. FEBS Lett 2005; 579: 5157-62.
(30.) Chatterjee A, Dutta PK, Chowdhury R. Effect of fatty acids and cholesterol present in bile on the expression of virulence factors & motility of Vibrio cholerae. Infect Immun 2007; 75: 1946-53.
(31.) Cichewicz RH, Thorpe PA. The antimicrobial properties of chili peppers (Capsicum species) and their use in Mayan medicine. J Ethnopharmacol 1996; 52: 61-70.
(32.) Jones NL, Shabib S, Sherman PM. Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol Lett 1997; 146: 223-7.
(33.) Morita M, Ohnishi M, Arakawa E, Bhuiyan NA, Nusrin S, Alam M. Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiol Immunol 2008; 52: 314-7.
(34.) Nair GB, Faruque SM, Bhuiyan NA, Kamruzzaman M, Siddique AK, Sack DA. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol 2002; 40: 3296-9.
(35.) Ghosh J, Senoh M, Hamabata T, Mukhopadhyay AK, Ramamurthy T, Chatterjee S, et al. New variants of Vibrio cholerae O1 El Tor produce higher levels of cholera toxin as compared to prototype El Tor strains. 13th International Conference on Emerging Infections Disease in the Pacific Rim, 2009; p54, Kolkata, India.
(36.) DiRita VJ, Parsot C, Jander G, Mekalanos JJ. Regulatory cascade controls virulence in Vibrio cholerae. Proc Natl Acad Sci USA 1991; 88: 5403-7.
(37.) Hase CC, Mekalanos JJ. TcpP protein is a positive regulator of virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci USA 1998; 95: 730-4.
(38.) Nye MB, Pfau JD, Skorupski K, Taylor RK. Vibrio cholerae H-NS silences virulence gene expression at multiple steps in the ToxR regulatory cascade. J Bacteriol 2000; 182: 4295-303.
(39.) Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 2005; 10: 670-4.
(40.) Skorupski K, Taylor RK. Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli. Mol Microbiol 1997; 25: 1003-9.
Reprint requests: Dr Shinji Yamasaki, Graduate School of Life & Environmental Sciences, Osaka Prefecture University 1-58, Rinku orai-kita, Izumisano-shi, Osaka 598-8531, Japan e-mail: firstname.lastname@example.org
Shinji Yamasaki, Masahiro Asakura, Sucharit Basu Neogi, Atsushi Hinenoya, Emiko Iwaoka * & Shunji Aoki *
Graduate School of Life & Environmental Sciences, Osaka Prefecture University, Osaka & * Faculty of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan
Table I. Natural compounds identified to act against diarrhoeagenic vibrios Plant Scientific name Specific compound Wasabi Wasabi japonica Allyl isothiocyanate Green tea Camellia sinensis Catechins Guazuma Guazuma ulimifolia Procyanidins Daio (Kampo Rhei rhizoma Gallate analogues formulation) Apple Malus spp. Apelphenon Hop Humulus lupulus Procyanidins Neem Azadirachta indica Unknown Elephant Allium Oil (diallyl garlic ampleloprasum sulphides) Red bayberry Myrica rubra Unknown Red chili Capsicum annum Capsaicin Plant Target Mechanism Wasabi V. parahaemolyticus Inhibit growth Green tea V. cholerae Inhibit growth and CT activity Guazuma V. cholerae CT activity Daio (Kampo V. cholerae CT activity formulation) Apple V. cholerae CT activity Hop V. cholerae CT activity Neem V. cholerae Inhibit growth Elephant V. cholerae Inhibit growth garlic Red bayberry V. cholerae Inhibit CT production Red chili V. cholerae Inhibit CT production Plant Reference Wasabi 10 Green tea 11 Guazuma 12 Daio (Kampo 13 formulation) Apple 14 Hop 15 Neem 16 Elephant 17 garlic Red bayberry 18 Red chili 19 Table II. Inhibition (%) of CT production in V. cholerae O1 El Tor variant strains (isolated from cholera patients in India) with six different commonly used spices methanol extract (100 [micro]g/ml) Strain Isolation Red Sweet White ID year chili fennel pepper CO533 1994 97 95 86 CRC27 2000 97 92 99 CRC41 2000 90 96 94 CRC87 2000 94 85 87 Strain Red Cassia Star ID pepper bark anise CO533 68 45 50 CRC27 80 79 66 CRC41 53 86 6.0 CRC87 56 78 29 Source: unpublished data
|Gale Copyright:||Copyright 2011 Gale, Cengage Learning. All rights reserved.|